| |
 |
Boston Biomedical Research Institute, Inc. Patents |
|
Assignee: Boston Biomedical Research Institute, Inc.
Address: Boston, MA
No. of patents: 4
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 5523210 |
Bispecific antibody determinants |
June 4, 1996 |
| A homogenous sample of identical bispecific antibody determinants, each determinant being composed of two L-H half-molecules linked by disulfide bonds, each L-H half-molecule being specific for a different antigenic determinant and including at least the F(ab') portion of a monoclonal Ig |
| 5292668 |
Bispecific antibody determinants |
March 8, 1994 |
| A homogenous sample of identical bispecific antibody determinants, each determinant being composed of two L-H half-molecules linked by disulfide bonds, each L-H half-molecule being specific for a different antigenic determinant and including at least the F(ab') portion of a monoclonal Ig |
| 4474742 |
Treatment of asbestos |
October 2, 1984 |
| Toxicity of asbestos is reduced by treating it with non-mutagenic non-toxic hydroxamic acid iron-chelating agents. |
| 4444878 |
Bispecific antibody determinants |
April 24, 1984 |
| A homogenous sample of identical bispecific antibody determinants, each determinant being composed of two L-H half-molecules linked by disulfide bonds, each L-H half-molecule being specific for a different antigenic determinant and including at least the F(ab') portion of a monoclonal Ig |
|
|
|
